Chk1 signaling pathways that mediated G(2)M checkpoint in relation to the cellular resistance to the novel topoisomerase I poison BNP1350. (Q38363888)

2 September 2017

title

Chk1 signaling pathways that mediated G(2)M checkpoint in relation to the cellular resistance to the novel topoisomerase I poison BNP1350. (English)

1 reference

2 September 2017

Ming-biao Yin

1

1 reference

2 September 2017

Gunnar Hapke

2

1 reference

2 September 2017

Jiaxi Wu

3

1 reference

2 September 2017

Rami G Azrak

4

1 reference

2 September 2017

Cheryl Frank

5

1 reference

2 September 2017

Carol Wrzosek

6

1 reference

2 September 2017

Youcef M Rustum

7

1 reference

2 September 2017

language of work or name

English

0 references

publication date

1 July 2002

1 reference

Biochemical and Biophysical Research Communications

2 September 2017

published in

1 reference

2 September 2017

volume

295

1 reference

2 September 2017

issue

2

1 reference

2 September 2017

page(s)

435-444

1 reference

The current status of camptothecin analogues as antitumor agents

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900683-6

Current perspectives on camptothecins in cancer treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900683-6

New highly lipophilic camptothecin BNP1350 is an effective drug in experimental human cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900683-6

Nonproductive rearrangement of DNA topoisomerase I and II genes: correlation with resistance to topoisomerase inhibitors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900683-6

Topoisomerase I is differently phosphorylated in two sublines of L5178Y mouse lymphoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900683-6

Lowered phosphorylation of topoisomerase I is a direct reason for reduced sensitivity of L5178Y-S cells to camptothecin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900683-6

Novel cellular determinants for reversal of multidrug resistance in cells expressing P170-glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900683-6

Cell cycle checkpoints: preventing an identity crisis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900683-6

Regulating the onset of mitosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900683-6

Fission yeast chk1 protein kinase links the rad checkpoint pathway to cdc2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900683-6

Identification and characterization of new elements involved in checkpoint and feedback controls in fission yeast

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900683-6

rad-dependent response of the chk1-encoded protein kinase at the DNA damage checkpoint.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900683-6

Characterization of protein kinase chk1 essential for the cell cycle checkpoint after exposure of human head and neck carcinoma A253 cells to a novel topoisomerase I inhibitor BNP1350

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900683-6

Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900683-6

Association of Chk1 with 14-3-3 proteins is stimulated by DNA damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900683-6

The Chk1-Cdc25C regulation is involved in sensitizing A253 cells to a novel topoisomerase I inhibitor BNP1350 by bax gene transfer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900683-6

Mechanisms of resistance to N-[5-[N-(3, 4-dihydro-2-methyl-4-oxoquinazolin-6-ylmethyl)-N-methylamino]-2-thenoyl]-L-glutamic acid (ZD1694), a folate-based thymidylate synthase inhibitor, in the HCT-8 human ileocecal adenocarcinoma cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900683-6

New colorimetric cytotoxicity assay for anticancer-drug screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900683-6

Separation of yeast chromosome-sized DNAs by pulsed field gradient gel electrophoresis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900683-6

Biochemical evidence for two different mechanisms for bleomycin-induced cell killing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900683-6

Regulation of Rad51 function by c-Abl in response to DNA damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900683-6

Radiation-induced assembly of Rad51 and Rad52 recombination complex requires ATM and c-Abl

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900683-6

Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900683-6

Functional link between ataxia-telangiectasia and Nijmegen breakage syndrome gene products

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900683-6

ATM phosphorylation of Nijmegen breakage syndrome protein is required in a DNA damage response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900683-6

hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900683-6

Replication-mediated DNA damage by camptothecin induces phosphorylation of RPA by DNA-dependent protein kinase and dissociates RPA:DNA-PK complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900683-6

Induction of biphasic DNA double strand breaks and activation of multiple repair protein complexes by DNA topoisomerase I drug 7-ethyl-10-hydroxy-camptothecin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900683-6

Cell-cycle regulation of mammalian DNA double-strand-break repair

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900683-6

DNA double strand break repair in mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900683-6

DNA double-strand breaks: signaling, repair and the cancer connection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900683-6

Chromosomal stability and the DNA double-stranded break connection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900683-6

Targeting molecular signals in chk1 pathways as a new approach for overcoming drug resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900683-6

Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900683-6

The Chk1 protein kinase and the Cdc25C regulatory pathways are targets of the anticancer agent UCN-01

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900683-6

UCN-01 selectively enhances mitomycin C cytotoxicity in p53 defective cells which is mediated through S and/or G(2) checkpoint abrogation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900683-6

UCN-01 abrogates G2 arrest through a Cdc2-dependent pathway that is associated with inactivation of the Wee1Hu kinase and activation of the Cdc25C phosphatase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900683-6

Enhancement of camptothecin-induced cytotoxicity with UCN-01 in breast cancer cells: abrogation of S/G(2) arrest

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900683-6

The topoisomerase I poison camptothecin generates a Chk1-dependent DNA damage checkpoint signal in fission yeast

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900683-6

Cell-cycle-dependent and ATM-independent expression of human Chk1 kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900683-6

An essential phosphorylation-site domain of human cdc25C interacts with both 14-3-3 and cyclins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900683-6

Nuclear localization of Cdc25 is regulated by DNA damage and a 14-3-3 protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900683-6

10.1016/S0006-291X(02)00683-6

7 January 2021

Identifiers

DOI

1 reference

2 September 2017

1 reference